
-
Stokes 'on track' for Ashes as England name squad
-
Djokovic to play Shanghai Masters in October
-
In US Ryder Cup pay spat, Schauffele and Cantlay giving all to charity
-
Congo's Nobel winner Mukwege pins hopes on new film
-
Scheffler expects Trump visit to boost USA at Ryder Cup
-
Top Madrid museum opens Gaza photo exhibition
-
Frank unfazed by trophy expectations at Spurs
-
US says dismantled telecoms shutdown threat during UN summit
-
Turkey facing worst drought in over 50 years
-
Cities face risk of water shortages in coming decades: study
-
Trump mocks UN on peace and migration in blistering return
-
Stokes named as England captain for Ashes tour
-
Does taking paracetamol while pregnant cause autism? No, experts say
-
We can build fighter jet without Germany: France's Dassault
-
Atletico owners negotiating with US firm Apollo over majority stake sale - reports
-
Stocks mark time with eyes on key economic data
-
Tabilo stuns Musetti for Chengdu title, Bublik wins in Hangzhou
-
Trump returns to UN to attack 'globalist' agenda
-
No.1 Scheffler plays down great expectations at Ryder Cup
-
WHO sees no autism links to Tylenol, vaccines
-
US Fed official urges proactive approach on rates to boost jobs market
-
Nearly 100 buffaloes die in Namibia stampede
-
UN chief warns 'aid cuts are wreaking havoc' amid slashed budgets
-
Schools shut, flights axed as Typhoon Ragasa nears Hong Kong, southern China
-
Hundreds trapped as typhoon triggers barrier lake burst in Taiwan
-
EU proposes new delay to anti-deforestation rules
-
Man City have 'recovered many things': Guardiola
-
Thailand to 'clarify misunderstandings' after SEA Games petanque ban
-
Denmark brands mystery drone flights 'serious' attack
-
Iran executed at least 1,000 this year in prison 'mass killing': NGO
-
France's Dassault says can build European fighter jet without Germany
-
Former umpire 'Dickie' Bird dies aged 92
-
Ghana deports at least six west Africans expelled by US to Togo
-
Bradley admits thoughts linger about having played in Ryder Cup
-
EU queries Apple, Google, Microsoft over financial scams
-
OECD raises world growth outlook as tariffs contained, for now
-
Former umpire Harold 'Dickie' Bird dies aged 92
-
Cycling worlds bring pride to African riders despite disadvantages
-
Stocks diverge with eyes on key economic data
-
German business groups pressure Merz over ailing economy
-
Drone flights 'most serious attack' on Danish infrastructure, PM says
-
Indonesia, EU sign long-awaited trade deal
-
Howe confident Newcastle will find 'X factor'
-
Trump returns to UN podium and Zelensky talks
-
Tech migrants 'key' for US growth, warns OECD chief economist
-
East Timor to become ASEAN bloc's 11th member in October
-
OECD ups world economic outlook as tariffs contained, for now
-
India bids tearful farewell to maverick musician
-
Sunset for Windows 10 updates leaves users in a bind
-
Hopes of Western refuge sink for Afghans in Pakistan
RBGPF | 0% | 76.6 | $ | |
CMSC | -0.62% | 24.1 | $ | |
BCC | -0.61% | 78.96 | $ | |
BTI | -1.82% | 52.905 | $ | |
RYCEF | 0.63% | 15.75 | $ | |
CMSD | -0.62% | 24.31 | $ | |
NGG | 0.01% | 70.965 | $ | |
GSK | -0.86% | 40.56 | $ | |
RIO | -0.02% | 63.638 | $ | |
SCS | 0.38% | 16.965 | $ | |
RELX | -1.31% | 46.47 | $ | |
VOD | -0.31% | 11.355 | $ | |
BP | 1.98% | 35.065 | $ | |
BCE | 0.1% | 23.092 | $ | |
JRI | 0.32% | 14.045 | $ | |
AZN | -1.71% | 76.2 | $ |

Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.
At street stalls where medicinal herbs are sold, customers can buy the plant's root which contains dimethyltryptamine (DMT), a hallucinogenic substance that researchers say could be used to alleviate symptoms.
Following instructions he found on the internet, Guaracy Carvajal extracted DMT at home in 2016 from roots he bought on the street.
The 31-year-old software programmer, who had tried various treatment for chronic depression he has suffered since adolescence, said the drug makes it "feel like you've solved something in your life."
Physicist Draulio Araujo, who has conducted extensive research on the drug, said "the response is rapid. One day after treatment, (patients) already showed a significant improvement in their depression symptoms."
Yet he also warned that it "is not a magic cure" and that psychedelics "are not for everyone."
As a researcher at the Brain Institute of the Federal University of Rio Grande do Norte, Araujo and his team treated 14 people with the drug for six months.
The patients inhaled vaporized DMT, under medical supervision.
"It's common for our patients to say that something changed, that a key opened something," he said.
His patients also received psychological therapy, and some continued with conventional pharmaceutical drugs.
Neuroscientist Fernanda Palhano-Fontes, also of the Brain Institute, said "we have patients who improve significantly, others who don't improve at all."
Araujo's findings were published in the scientific journal Nature in April. In 2024, he published another study with promising results in the journal Psychedelic Medicine.
As for Carvajal, who stopped using jurema preta some time ago, he said the drug really allows a person to "start to have a lighter life."
It helped him get through a time when he was in "a state of questioning myself" about "work, day-to-day life," he said.
- Spiritual channels -
Brazil occupies a fairly prominent place in DMT research due to the substance's prominence in society, Araujo said.
While there is no ban on the cultivation or possession of jurema, which is also known as Mimosa tenuiflora, consumption of DMT is prohibited, except for religious and scientific use.
Jurema's roots are combined with other plants in a wine-like beverage that is consumed at rituals that include dancing and drums, part of Indigenous tradition in northeast Brazil where the plant grows.
"It's not hallucination," said Joyce Souza, a young woman attending a jurema ceremony in Planaltina, on the outskirts of Brasília.
"My spiritual channels become more accessible, I can communicate better with myself," Souza said.
Gathered in a house courtyard and dressed in white, the group of mostly novices waited for more seasoned practitioners to enter a trance and bring messages from ancient spirits.
Meanwhile, back in the lab, Araujo is hoping to expand his DMT research to a study of 100 patents.
"Let's say that in five years we'll have... a clear picture on when it will reach a real clinical setting," he said.
F.AbuZaid--SF-PST